Peter Czermak, Ph.D.

hMSC Production in Disposable Bioreactors in Compliance with cGMP Guidelines and PAT
Friday, April 25, 2014
Cell-based therapies continue to gain more and more importance within the multibillion-dollar market of biopharmaceutical products and continue to exemplify above-average growth possibilities [1-5]. Stem cells in particular ... read more

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary
print or digital subscription

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.